Crucial Cancer Screening Advice
Health Experts Highlight Vital Screening and Risks for Breast and Endometrial Cancers
Anonymous
Key Points
1
The RACGP said breast cancer is the most-diagnosed cancer among Australian women and the fifth most-common cause of cancer deaths there. It also noted that it and 20 patient representative bodies had urged Parliament to ensure patients can access longer GP consultations.
2
Endometrial cancer is usually diagnosed with a biopsy of the uterine lining, often in a doctor’s office. About 70% of patients can be treated with surgery alone, though treatment depends on the stage.
3
Jo Brown’s NHS GP referred her through the urgent two-week cancer pathway; repeat tests found stage 2 high-grade endometrial cancer after her private doctor’s earlier assessment had found nothing.
4
The gynecologic oncologist interviewed by Business Report said endometrial cancer is the most common cancer treated at her hospital and the fifth-leading cause of cancer-related deaths in women.
A Cincinnati woman discovered an inherited breast cancer risk through genetic testing, leading doctors to find noninvasive cancer that she chose to treat with a double mastectomy WCPO. Meanwhile, health experts are raising alarms about endometrial cancer, warning that abnormal uterine bleeding—especially after menopause—can signal the disease and demands urgent medical attention Business Report.
Endometrial cancer killed more than 100,000 women globally in 2024, with cases exceeding 434,000, yet many cases go undiagnosed until advanced stages Health Experts. Australian doctors are pushing for longer, funded GP consultations to catch both breast and endometrial cancers earlier through better screening and patient conversations RACGP.
A Young Woman's Early Detection Victory
Ashley Holbrook, a bride-to-be, learned through genetic testing that she carried an inherited breast cancer risk WCPO. Screening at Christ Hospital's High Risk Clinic found noninvasive cancer early—before it could spread or threaten her wedding. Her doctors recommended a double mastectomy, and pathology showed no need for additional whole-body chemotherapy or radiation.
Her case underscores why genetic testing matters. Women with inherited mutations face much higher lifetime breast cancer risk. Early detection through screening and quick action can prevent invasive disease. Holbrook's decision to have both breasts removed eliminated the cancer threat and let her move forward with her life.
Endometrial Cancer Often Missed Until It's Advanced
Jo Brown ignored warning signs for months. Persistent pelvic pain and worsening abnormal bleeding prompted her to seek a second opinion after a private doctor's earlier exam had reassured her Business Report. That second assessment—via an urgent NHS two-week cancer pathway—revealed stage 2 high-grade endometrial cancer.
A gynecologic oncologist noted that endometrial cancer is the most common cancer her hospital treats and the fifth-leading cause of cancer deaths in women Business Report. Yet many cases are caught late because symptoms—abnormal bleeding, especially after menopause—get dismissed as normal aging. Doctors stress: any unusual vaginal bleeding warrants prompt evaluation.
Screening and Longer Doctor Visits Could Save Lives
The Royal Australian College of General Practitioners (RACGP) reports that breast cancer is the most-diagnosed cancer among Australian women and the fifth-leading cause of cancer deaths RACGP. The RACGP and 20 patient groups have urged Parliament to fund longer GP consultations so doctors have time to discuss cancer risk, screening options, and unusual symptoms thoroughly.
Endometrial cancer is usually diagnosed with a biopsy of the uterine lining, often done in a doctor's office Health Experts. About 70% of patients can be treated with surgery alone, though stage and grade determine the full treatment plan. Better prevention conversations and faster diagnostic pathways could catch more cases early, when outcomes are best.
Why Risk Factors and Aging Drive Endometrial Cancer Rates
Global endometrial cancer cases exceeded 434,000 in 2024, with over 100,000 deaths, according to health reports Health Experts. Obesity, diabetes, aging, and hormonal factors all boost risk. Women over 60 face the highest incidence, though younger women with genetic predispositions or metabolic conditions can develop it too.
The takeaway: women must know their cancer risk—through family history, genetic testing, or metabolic health—and report any abnormal bleeding immediately. Doctors must listen and investigate promptly. Early detection transforms outcomes from life-threatening to manageable, as Holbrook's and Brown's cases show.
Sentiment
Mostly NegativeNEGATIVENEUTRALPOSITIVE
Publishers
38
Articles
18
Reach
56
A
AnonymousAuthor
